Signal transduction pathways in acute myetoid leukemia
Promotie: mw. L. Han, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Signal transduction pathways in acute myetoid leukemia
Promotor(s): prof.dr. E. Vellenga
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Signal transduction pathways in acute myetoid leukemia
Acute myeloid leukemia (AML) is characterized by the uncontrolled accumulation of abnormal white blood cells in the bone marrow that replace normal blood cells, including red blood cells, platelets and normal white blood cells. The symptoms include fatigue, shortness of breath, bleeding, and high risk of infection. Emerging studies consider that leukemic stem cells (LSCs) initiate and maintain AML, and their quiescent state contributes to resistance of chemotherapy. A number of abnormal signaling pathways have been identified in AML LSCs. A novel inhibitor dasatinib was demonstrated to be a potential inhibitor in a subgroup of AML.
Last modified: | 13 March 2020 01.16 a.m. |
More news
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.
-
02 April 2024
Flying on wood dust
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
18 March 2024
VentureLab North helps researchers to develop succesful startups
It has happened to many researchers. While working, you suddenly ask yourself: would this not be incredibly useful for people outside of my own research discipline? There are many ways to share the results of your research. For example, think of a...